Jan 5, 2023 07:00AM

Jan 5, 2023 07:00AM

Dec 19, 2022 07:02AM

Dec 19, 2022 07:00AM

Dec 19, 2022 07:00AM

Dec 5, 2022 07:00AM

Dec 5, 2022 07:00AM European Commission approves Mycapssa® for the treatment of Acromegaly

Nov 30, 2022 07:00AM

Nov 30, 2022 07:00AM

Nov 3, 2022 07:00AM

Nov 3, 2022 07:00AM

Oct 31, 2022 07:00AM

Oct 25, 2022 07:00AM

Oct 25, 2022 07:00AM The British Journal of Dermatology Publishes Results from Amryt’s EASE Phase 3 Trial in Epidermolysis Bullosa

Oct 25, 2022 07:00AM

Oct 24, 2022 07:00AM

Oct 19, 2022 07:00AM

Oct 18, 2022 07:00AM

Oct 18, 2022 07:00AM

Oct 17, 2022 07:01AM

Oct 17, 2022 07:00AM Amryt Receives Reimbursement Approval from the Dutch Ministry of Health for Myalepta® (metreleptin)

Oct 17, 2022 07:00AM

Sep 23, 2022 07:00AM

Sep 16, 2022 07:30AM

Sep 16, 2022 07:30AM

Sep 16, 2022 07:30AM

Sep 13, 2022 07:04AM

Sep 13, 2022 07:00AM Amryt Announces New Patent for Mycapssa®

Sep 13, 2022 07:00AM

Sep 8, 2022 07:00AM

Sep 8, 2022 07:00AM

Sep 7, 2022 07:00AM

Sep 7, 2022 07:00AM

Aug 4, 2022 07:00AM

Aug 4, 2022 07:00AM Amryt Reports Record Q2 2022 Results

Jul 21, 2022 07:00AM

Jul 21, 2022 07:00AM

Jul 14, 2022 07:00AM

Jul 14, 2022 07:00AM

Jul 7, 2022 07:01AM

Jul 7, 2022 07:00AM

Jul 7, 2022 07:00AM Amryt Presents New Analyses from the EASE Phase 3 Trial in Epidermolysis Bullosa at SPD 2022

Jul 1, 2022 07:00AM

Jul 1, 2022 07:00AM

Jun 27, 2022 07:00AM

Jun 27, 2022 07:00AM

Jun 24, 2022 07:00AM

Jun 24, 2022 07:00AM

Jun 24, 2022 07:00AM Amryt to Pursue Formal Dispute Resolution for Oleogel-S10 (Filsuvez®) NDA

Jun 23, 2022 07:00AM

64,524 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All